362 Novel Stony Brook taxanes are efficacious in paclitaxel-resistant ovarian cancer models both in vitro and in vivo | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

362 Novel Stony Brook taxanes are efficacious in paclitaxel-resistant ovarian cancer models both in vitro and in vivo

Free

Online download statistics by month:

Online download statistics by month: October 2021 to April 2024

	Abstract	Full	Pdf
Oct 2021	44	0	9
Nov 2021	42	0	12
Dec 2021	8	0	0
Jan 2022	39	0	6
Feb 2022	12	0	1
Mar 2022	14	0	5
Apr 2022	5	0	4
May 2022	28	0	14
Jun 2022	22	0	4
Jul 2022	41	0	5
Aug 2022	21	0	3
Sep 2022	18	0	5
Oct 2022	33	0	9
Nov 2022	19	0	3
Dec 2022	18	0	4
Jan 2023	25	0	7
Feb 2023	14	0	2
Mar 2023	8	0	0
Apr 2023	12	0	2
May 2023	4	0	0
Jun 2023	7	0	2
Jul 2023	6	0	8
Aug 2023	24	0	10
Sep 2023	5	0	1
Oct 2023	4	0	0
Nov 2023	86	0	17
Dec 2023	23	0	0
Jan 2024	17	0	1
Feb 2024	10	0	1
Mar 2024	16	0	5
Apr 2024	14	0	6
Total	639	0	146